OrthoPediatrics (KIDS) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

OrthoPediatrics (KIDS) overview

OrthoPediatrics (KIDS) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 236m and operating profit of USD -39.2m; the year-end share price was 17.76 USD and market capitalisation was USD 446m. OrthoPediatrics is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get OrthoPediatrics's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 347mFY 2025
Share price17.76 USDFY 2025 year end
RevenueUSD 236mFY 2025
Operating profitUSD -39.2mFY 2025
Net earningsUSD -39.6mFY 2025
Market capitalisationUSD 446mFY 2025 year end

About OrthoPediatrics

OrthoPediatrics designs, develops and markets orthopedic implants, surgical instruments and specialized braces for children with orthopedic conditions. Its products are sold to hospitals and medical facilities in the United States and international markets. The company uses contract manufacturers for implants and related instrumentation, typically makes braces in-house, and operates orthotic and prosthetic clinics that provide pediatric nonsurgical treatment.

Generate the OrthoPediatrics report

OrthoPediatrics is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for OrthoPediatrics and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on OrthoPediatrics

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.